Bryansk Regional Hospital 1

Bryansk 241033

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed